A recent press release gives details of a clinical trial which is taking place in Southampton.
Stargardt’s disease, also known as Stargardt‘s macular dystrophy, affects the area of the retina called the macula and causes a reduction in central vision.
It is the most common form of juvenile macular degeneration and affects around one in 10,000 children who suffer a gradual decline in vision which leads to blindness in adulthood. The press release gives full details.
The study has been funded by the European Union.
If you would like to register your interest in this project please send an email to EyeResearch@uhs.nhs.uk